BIOC
Income statement / Annual
Last year (2022), Biocept, Inc.'s total revenue was $25.86 M,
a decrease of 57.78% from the previous year.
In 2022, Biocept, Inc.'s net income was -$32.09 M.
See Biocept, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$25.86 M
|
$61.25 M
|
$27.46 M
|
$5.53 M
|
$3.25 M
|
$5.07 M
|
$3.22 M
|
$609,909.00
|
$133,415.00
|
$134,245.00
|
| Cost of Revenue |
$28.44 M |
$37.76 M |
$21.34 M |
$10.98 M |
$10.05 M |
$9.35 M |
$6.92 M |
$4.60 M |
$2.17 M |
$2.33 M |
| Gross Profit |
-$2.58 M |
$23.49 M |
$6.12 M |
-$5.45 M |
-$6.80 M |
-$4.28 M |
-$3.70 M |
-$3.99 M |
-$2.04 M |
-$2.20 M |
| Gross Profit Ratio |
-0.1 |
0.38 |
0.22 |
-0.99 |
-2.09 |
-0.84 |
-1.15 |
-6.54 |
-15.27 |
-16.36 |
| Research and Development
Expenses |
$6.16 M
|
$4.96 M
|
$5.22 M
|
$4.70 M
|
$4.47 M
|
$3.36 M
|
$2.71 M
|
$2.86 M
|
$4.50 M
|
$3.09 M
|
| General & Administrative
Expenses |
$16.11 M
|
$12.61 M
|
$9.97 M
|
$6.97 M
|
$7.07 M
|
$7.19 M
|
$6.56 M
|
$5.69 M
|
$5.20 M
|
$2.51 M
|
| Selling & Marketing
Expenses |
$7.13 M
|
$8.32 M
|
$6.40 M
|
$5.94 M
|
$5.91 M
|
$6.34 M
|
$5.05 M
|
$3.88 M
|
$2.14 M
|
$148,903.00
|
| Selling, General &
Administrative Expenses |
$23.24 M
|
$20.93 M
|
$16.37 M
|
$12.91 M
|
$12.99 M
|
$13.53 M
|
$11.61 M
|
$9.57 M
|
$7.34 M
|
$2.66 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
-$1.83 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$29.40 M |
$25.89 M |
$21.59 M |
$17.61 M |
$17.46 M |
$16.90 M |
$14.33 M |
$12.42 M |
$11.84 M |
$5.75 M |
| Cost And Expenses |
$57.84 M |
$63.66 M |
$42.93 M |
$28.59 M |
$27.51 M |
$26.24 M |
$21.25 M |
$17.02 M |
$14.01 M |
$8.08 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$316,000.00 |
$290,000.00 |
$2.34 M |
$2.08 M |
$310,976.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$2.07 M |
| Depreciation &
Amortization |
$1.66 M
|
$2.64 M
|
$1.00 M
|
$773,314.00
|
$800,905.00
|
$575,717.00
|
$322,029.00
|
$261,409.00
|
$251,203.00
|
$266,554.00
|
| EBITDA |
-$30.33 M
|
-$2.41 M
|
-$15.47 M
|
-$23.06 M
|
-$24.26 M
|
-$21.17 M
|
-$18.03 M
|
-$16.41 M
|
-$13.87 M
|
-$7.68 M
|
| EBITDA Ratio |
-1.17 |
-0.04 |
-0.56 |
-4.17 |
-7.46 |
-4.18 |
-5.59 |
-26.91 |
-103.99 |
-57.19 |
| Operating Income Ratio
|
-1.24
|
-0.04
|
-0.56
|
-4.17
|
-7.46
|
-4.18
|
-5.59
|
-26.91
|
-103.99
|
-59.18
|
| Total Other
Income/Expenses Net |
-$229,000.00
|
-$290,000.00
|
-$2.34 M
|
-$2.08 M
|
-$310,976.00
|
-$431,407.00
|
-$372,232.00
|
-$537,115.00
|
-$1.99 M
|
-$1.29 M
|
| Income Before Tax |
-$32.21 M |
-$2.70 M |
-$17.81 M |
-$25.14 M |
-$24.57 M |
-$21.61 M |
-$18.40 M |
-$16.95 M |
-$15.86 M |
-$9.23 M |
| Income Before Tax Ratio
|
-1.25
|
-0.04
|
-0.65
|
-4.55
|
-7.56
|
-4.26
|
-5.71
|
-27.79
|
-118.91
|
-68.77
|
| Income Tax Expense |
-$125,000.00 |
$125,000.00 |
-$764,584.00 |
-$523,330.00 |
$1,886.00 |
$7,624.00 |
$2,053.00 |
$1,608.00 |
$1,506.00 |
$800.00 |
| Net Income |
-$32.09 M |
-$2.82 M |
-$17.04 M |
-$24.61 M |
-$24.57 M |
-$21.61 M |
-$18.40 M |
-$16.95 M |
-$15.87 M |
-$9.23 M |
| Net Income Ratio |
-1.24 |
-0.05 |
-0.62 |
-4.45 |
-7.56 |
-4.26 |
-5.71 |
-27.79 |
-118.92 |
-68.78 |
| EPS |
-56.78 |
-5.73 |
-43.16 |
-357.54 |
-2634.46 |
-7074.87 |
-17292.6 |
-23282.32 |
-96744.18 |
-55288.52 |
| EPS Diluted |
-56.78 |
-5.73 |
-43.16 |
-357.41 |
-2634.46 |
-7074.87 |
-17292.6 |
-23282.32 |
-96744.18 |
-55288.52 |
| Weighted Average Shares
Out |
$565,127.00
|
$492,526.00
|
$394,841.00
|
$68,845.00
|
$9,327.00
|
$3,055.00
|
$1,064.00
|
$728.00
|
$164.00
|
$167.00
|
| Weighted Average Shares
Out Diluted |
$565,127.00
|
$492,526.00
|
$394,841.00
|
$68,869.00
|
$9,327.00
|
$3,055.00
|
$1,064.00
|
$728.00
|
$164.00
|
$167.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
